Person · CIK 1823563

Rebecca Chambers

Chief Financial Officer at Veracyte; director at Alamar Biosciences and Inari Medical

Earlier: Outset Medical

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$6.3M

Noticed on Form 144$2.8M

Bought on Form 4$0

Companies4

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Veracyte VCYT	Common Stock	Directly	166,025	Sep 4, 2026 · Filing · EDGAR
Veracyte VCYT	Stock Option (right to buy) exercise $23.73, expires Mar 6, 2033, into Common Stock	Directly	42,956	Mar 6, 2023 · Filing · EDGAR
Alamar Biosciences ALMR	Stock Option (Right to Buy) exercise $7.60, expires Jan 14, 2036, into Common Stock	Directly	140,612	Apr 20, 2026 · Filing · EDGAR
Outset Medical	Common Stock	Directly	13,597	Jun 24, 2021 · Filing · EDGAR
Outset Medical	Non-Qualified Stock Option (right to buy) exercise $6.25, expires Sep 10, 2029, into Common Stock	Directly	77,745	Jun 24, 2021 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q3 2026	$157K	$163K
Q2 2026	$177K	$173K
Q1 2026	$663K	$643K
Q4 2025	$909K	$887K
Q1 2025	$23K	—
Q4 2024	$888K	$926K
Q2 2024	$56K	$56K
Q2 2021	$2.5M	Not machine-readable
Q1 2021	$835K	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Aug 21, 2025 · 4 notices
Sep 4, 2026	3,652 · ~$163K	Sep 4, 2026	Sold as noticed Sold 3,652 in 2 sales, Sep 4 to Sep 4 · $157K Form 4	Filing · EDGAR
Jun 4, 2026	3,561 · ~$173K	Jun 4, 2026	Sold as noticed Sold 3,561 in 2 sales, Jun 4 to Jun 4 · $177K Form 4	Filing · EDGAR
Mar 4, 2026	18,341 · ~$643K	Mar 4, 2026	Sold as noticed Sold 18,341 in 2 sales, Mar 4 to Mar 4 · $663K Form 4	Filing · EDGAR
Dec 4, 2025	13,278 · ~$634K	Dec 4, 2025	Sold as noticed Sold 13,278 in 2 sales, Dec 4 to Dec 4 · $622K Form 4	Filing · EDGAR
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Aug 13, 2024 · 3 notices
Nov 5, 2025	7,000 · ~$253K	Nov 5, 2025	Sold as noticed Sold 7,000 at $41.00 on Nov 5 · $287K Form 4	Filing · EDGAR
Dec 3, 2024	7,527 · ~$332K	Dec 3, 2024	Sold as noticed Sold 7,527 in 2 sales, Dec 3 to Feb 3 · $326K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Nov 12, 2024	15,275 · ~$594K	Nov 12, 2024	Sold as noticed Sold 15,275 at $38.34 on Nov 12 · $586K Form 4	Filing · EDGAR
Inari Medical NARI · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 6, 2023 · 1 notice
May 20, 2024	1,224 · ~$56K	May 20, 2024	Sold as noticed Sold 1,224 in 2 sales, May 20 to Jun 21 · $56K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Sales without a matching Form 144 · 6 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Outset Medical: Sold 16,727 at $50.72 on Jun 24, 2021 · $848K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Outset Medical: Sold 16,727 at $45.11 on May 25, 2021 · $755K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Outset Medical: Sold 8,228 at $56.89 on Apr 27, 2021 · $468K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Outset Medical: Sold 8,499 at $56.33 on Apr 27, 2021 · $479K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Outset Medical: Sold 13,135 at $50.16 on Mar 25, 2021 · $659K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Outset Medical: Sold 3,592 at $49.11 on Mar 25, 2021 · $176K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Veracyte VCYT Chief Financial Officer · filings 2021 to 2026 · sold $2.8M · $2.8M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 4, 2026	Sale under a 10b5-1 plan	−2,477	$42.81	$106K	167,200 direct	Filing · EDGAR
Sep 4, 2026	Sale under a 10b5-1 plan	−1,175	$43.71	$51K	166,025 direct	Filing · EDGAR
Sep 2, 2026	Shares withheld for tax or exercise price	−3,603	$44.88	$162K	169,677 direct	Filing · EDGAR
Jun 4, 2026	Sale under a 10b5-1 plan	−1,600	$49.28	$79K	175,241 direct	Filing · EDGAR
Jun 4, 2026	Sale under a 10b5-1 plan	−1,961	$50.09	$98K	173,280 direct	Filing · EDGAR
Jun 2, 2026	Shares withheld for tax or exercise price	−3,693	$47.80	$177K	176,841 direct	Filing · EDGAR
Mar 6, 2026	Grant or award from the company	+36,181			167,377 direct	Filing · EDGAR
Mar 6, 2026	Grant or award from the company	+13,157			180,534 direct	Filing · EDGAR
Mar 4, 2026	Sale under a 10b5-1 plan	−4,400	$35.55	$156K	145,137 direct	Filing · EDGAR
Mar 4, 2026	Sale under a 10b5-1 plan	−13,941	$36.33	$506K	131,196 direct	Filing · EDGAR
Mar 2, 2026	Shares withheld for tax or exercise price	−7,234	$36.01	$260K	149,537 direct	Filing · EDGAR
Feb 26, 2026	Grant or award from the company	+59,324			168,820 direct	Filing · EDGAR
Feb 26, 2026	Shares withheld for tax or exercise price	−12,049	$38.75	$467K	156,771 direct	Filing · EDGAR
Dec 4, 2025	Sale under a 10b5-1 plan	−8,537	$46.61	$398K	114,237 direct	Filing · EDGAR
Dec 4, 2025	Sale under a 10b5-1 plan	−4,741	$47.25	$224K	109,496 direct	Filing · EDGAR
Dec 2, 2025	Shares withheld for tax or exercise price	−3,384	$46.16	$156K	122,774 direct	Filing · EDGAR
Nov 5, 2025	Sale under a 10b5-1 plan	−7,000	$41.00	$287K	126,158 direct	Filing · EDGAR
Sep 2, 2025	Shares withheld for tax or exercise price	−5,371	$30.11	$162K	133,158 direct	Filing · EDGAR
Jun 2, 2025	Shares withheld for tax or exercise price	−5,370	$26.74	$144K	138,529 direct	Filing · EDGAR
Mar 6, 2025	Grant or award from the company	+30,200			143,899 direct	Filing · EDGAR
Mar 2, 2025	Shares withheld for tax or exercise price	−11,070	$34.76	$385K	113,699 direct	Filing · EDGAR
Feb 27, 2025	Grant or award from the company	+23,170			136,680 direct	Filing · EDGAR
Feb 27, 2025	Shares withheld for tax or exercise price	−11,911	$33.84	$403K	124,769 direct	Filing · EDGAR
Feb 3, 2025	Sale under a 10b5-1 plan	−527	$43.85	$23K	113,510 direct	Filing · EDGAR
Dec 3, 2024	Sale under a 10b5-1 plan	−7,000	$43.23	$303K	114,037 direct	Filing · EDGAR
Dec 2, 2024	Shares withheld for tax or exercise price	−3,464	$44.12	$153K	121,037 direct	Filing · EDGAR
Nov 12, 2024	Sale under a 10b5-1 plan	−15,275	$38.34	$586K	124,501 direct	Filing · EDGAR
Sep 2, 2024	Shares withheld for tax or exercise price	−3,464	$31.55	$109K	139,776 direct	Filing · EDGAR
Jun 2, 2024	Shares withheld for tax or exercise price	−3,462	$20.75	$72K	143,240 direct	Filing · EDGAR
Mar 15, 2024	Grant or award from the company	+4,318			148,891 direct	Filing · EDGAR
Mar 15, 2024	Shares withheld for tax or exercise price	−2,189	$21.10	$46K	146,702 direct	Filing · EDGAR
Mar 6, 2024	Grant or award from the company	+59,856			144,573 direct	Filing · EDGAR
Mar 2, 2024	Shares withheld for tax or exercise price	−6,112	$24.00	$147K	84,717 direct	Filing · EDGAR
Dec 2, 2023	Shares withheld for tax or exercise price	−1,800	$26.54	$48K	90,829 direct	Filing · EDGAR
Sep 2, 2023	Shares withheld for tax or exercise price	−3,652	$26.70	$98K	92,629 direct	Filing · EDGAR
Jun 2, 2023	Shares withheld for tax or exercise price	−1,183	$26.72	$32K	95,754 direct	Filing · EDGAR
Mar 6, 2023	Grant or award from the company	+26,014			96,937 direct	Filing · EDGAR
Mar 6, 2023	Grant or award from the company Stock Option (right to buy)	+42,956			42,956 direct	Filing · EDGAR
Mar 2, 2023	Shares withheld for tax or exercise price	−2,726	$24.10	$66K	70,923 direct	Filing · EDGAR
Dec 2, 2022	Shares withheld for tax or exercise price	−735	$29.14	$21K	72,998 direct	Filing · EDGAR
Sep 2, 2022	Shares withheld for tax or exercise price	−3,023	$19.18	$58K	73,733 direct	Filing · EDGAR
Aug 5, 2022	Grant or award from the company	+21,404			76,756 direct	Filing · EDGAR
Aug 5, 2022	Grant or award from the company Common Stock	+36,496			36,496 direct	Filing · EDGAR
Mar 3, 2022	Grant or award from the company	+20,728			54,728 direct	Filing · EDGAR
Mar 3, 2022	Grant or award from the company Stock Option (right to buy)	+37,773			37,773 direct	Filing · EDGAR
Jul 19, 2021	Grant or award from the company	+34,000			34,000 direct	Filing · EDGAR
Jul 19, 2021	Grant or award from the company Stock Option (right to buy)	+67,000			67,000 direct	Filing · EDGAR

Alamar Biosciences ALMR Director · filings 2026 to 2026

Date	Transaction	Shares	Price	Value	Held after	Source
Apr 20, 2026	Other acquisition or disposition (see the filing) Stock Option (Right to Buy)	−140,612			0 direct	Filing · EDGAR
Apr 20, 2026	Other acquisition or disposition (see the filing) Stock Option (Right to Buy)	+140,612			140,612 direct	Filing · EDGAR

Inari Medical NARI Director · filings 2021 to 2025 · sold $56K · $56K noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Feb 19, 2025	Tendered in a change of control	−9,684			0 direct	Filing · EDGAR
Jun 21, 2024	Sale under a 10b5-1 plan	−260	$45.99	$12K	9,684 direct	Filing · EDGAR
May 20, 2024	Sale under a 10b5-1 plan	−964	$45.39	$44K	9,944 direct	Filing · EDGAR
Apr 24, 2024	Grant or award from the company	+4,126	$42.41	$175K	10,908 direct	Filing · EDGAR
May 18, 2023	Grant or award from the company	+2,412			6,782 direct	Filing · EDGAR
May 26, 2022	Grant or award from the company	+2,420			4,370 direct	Filing · EDGAR
Jun 21, 2021	Grant or award from the company	+1,950			1,950 direct	Filing · EDGAR

Outset Medical Chief Financial Officer · filings 2020 to 2021 · sold $3.4M

Date	Transaction	Shares	Price	Value	Held after	Source
Jun 24, 2021	Option or RSU exercised or converted	+16,727	$6.25	$105K	30,324 direct	Filing · EDGAR
Jun 24, 2021	Sale under a 10b5-1 plan	−16,727	$50.72	$848K	13,597 direct	Filing · EDGAR
Jun 24, 2021	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−16,727			77,745 direct	Filing · EDGAR
May 25, 2021	Option or RSU exercised or converted	+16,727	$6.25	$105K	30,324 direct	Filing · EDGAR
May 25, 2021	Sale under a 10b5-1 plan	−16,727	$45.11	$755K	13,597 direct	Filing · EDGAR
May 25, 2021	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−16,727			94,472 direct	Filing · EDGAR
Apr 27, 2021	Option or RSU exercised or converted	+16,727	$6.25	$105K	30,324 direct	Filing · EDGAR
Apr 27, 2021	Sale under a 10b5-1 plan	−8,499	$56.33	$479K	21,825 direct	Filing · EDGAR
Apr 27, 2021	Sale under a 10b5-1 plan	−8,228	$56.89	$468K	13,597 direct	Filing · EDGAR
Apr 27, 2021	Option or RSU exercised or converted Stock Option (Right to Buy)	−16,727			111,199 direct	Filing · EDGAR
Mar 25, 2021	Option or RSU exercised or converted	+16,727	$6.25	$105K	30,324 direct	Filing · EDGAR
Mar 25, 2021	Sale under a 10b5-1 plan	−3,592	$49.11	$176K	26,732 direct	Filing · EDGAR
Mar 25, 2021	Sale under a 10b5-1 plan	−13,135	$50.16	$659K	13,597 direct	Filing · EDGAR
Mar 25, 2021	Option or RSU exercised or converted Stock Option (Right to Buy)	−16,727			127,926 direct	Filing · EDGAR
Mar 15, 2021	Grant or award from the company Stock Option (Right to Buy)	+27,037			27,037 direct	Filing · EDGAR
Mar 15, 2021	Grant or award from the company	+13,597			13,597 direct	Filing · EDGAR

All 56 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Sep 4, 2026	Form 144	Veracyte VCYT	Filing · EDGAR
Sep 4, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 4, 2026	Form 144	Veracyte VCYT	Filing · EDGAR
Jun 4, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Apr 20, 2026	Form 4	Alamar Biosciences ALMR	Filing · EDGAR
Apr 16, 2026	Form 3	Alamar Biosciences ALMR	Filing · EDGAR
Mar 10, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 6, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 4, 2026	Form 144	Veracyte VCYT	Filing · EDGAR
Mar 4, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 2, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Dec 4, 2025	Form 144	Veracyte VCYT	Filing · EDGAR
Dec 4, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Nov 7, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Nov 5, 2025	Form 144	Veracyte VCYT	Filing · EDGAR
Sep 4, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 4, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 10, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 3, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Feb 19, 2025	Form 4	Inari Medical NARI	Filing · EDGAR
Feb 5, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Dec 4, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Dec 3, 2024	Form 144	Veracyte VCYT	Filing · EDGAR
Nov 14, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Nov 12, 2024	Form 144	Veracyte VCYT	Filing · EDGAR
Sep 4, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 24, 2024	Form 4	Inari Medical NARI	Filing · EDGAR
Jun 4, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
May 21, 2024	Form 4	Inari Medical NARI	Filing · EDGAR
May 20, 2024	Form 144	Inari Medical NARI	Filing · EDGAR
Apr 26, 2024	Form 4	Inari Medical NARI	Filing · EDGAR
Mar 19, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 8, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 5, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Dec 5, 2023	Form 4	Veracyte VCYT	Filing · EDGAR
Sep 6, 2023	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 6, 2023	Form 4	Veracyte VCYT	Filing · EDGAR
May 19, 2023	Form 4	Inari Medical NARI	Filing · EDGAR
Mar 9, 2023	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 3, 2023	Form 4	Veracyte VCYT	Filing · EDGAR
Dec 6, 2022	Form 4	Veracyte VCYT	Filing · EDGAR
Sep 7, 2022	Form 4	Veracyte VCYT	Filing · EDGAR
Aug 9, 2022	Form 4	Veracyte VCYT	Filing · EDGAR
May 27, 2022	Form 4	Inari Medical NARI	Filing · EDGAR
Mar 7, 2022	Form 4	Veracyte VCYT	Filing · EDGAR
Jul 20, 2021	Form 4	Veracyte VCYT	Filing · EDGAR
Jul 20, 2021	Form 3	Veracyte VCYT	Filing · EDGAR
Jun 25, 2021	Form 4	Outset Medical	Filing · EDGAR
Jun 22, 2021	Form 3	Inari Medical NARI	Filing · EDGAR
Jun 22, 2021	Form 4	Inari Medical NARI	Filing · EDGAR
May 26, 2021	Form 4	Outset Medical	Filing · EDGAR
Apr 28, 2021	Form 4	Outset Medical	Filing · EDGAR
Mar 29, 2021	Form 4	Outset Medical	Filing · EDGAR
Mar 18, 2021	Form 4/A	Outset Medical	Filing · EDGAR
Mar 17, 2021	Form 4	Outset Medical	Filing · EDGAR
Sep 14, 2020	Form 3	Outset Medical	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 8, 2026, 7:05 AM ET. The filing on SEC.gov is the record.